newdrugapprovals.org
FDA grants breakthrough status for Pfizer’s leukaemia drug inotuzumab ozogamicin
Inotuzumab ozogamicin RN: 635715-01-4 UNII: P93RUU11P7 Pfizer Inc., Oncology Institute Of Southern Switzerland INNOVATOR MF 1680.6764 Oncological Treatment FDA grants breakthrough status fo…